EP 3 318 248-B1 results from a divisional application of EP 2 506 857. It relates to the delivery of mRNA for the augmentation of proteins and enzymes in human genetic diseases.
Brief outline of the case
The proprietor filed a new MR in opposition. The MR and AR1-3 lacked sufficiency and the patent was revoked.